...
首页> 外文期刊>Radiology >Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation.
【24h】

Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation.

机译:子宫平滑肌瘤:在聚焦超声热消融期间基于MR成像的测温和热剂量测定。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To retrospectively evaluate magnetic resonance (MR) imaging-based thermometry and thermal dosimetry during focused ultrasound treatments of uterine leiomyomas (ie, fibroids). MATERIALS AND METHODS: All patients gave written informed consent for the focused ultrasound treatments and the current HIPAA-compliant retrospective study, both of which were institutional review board approved. Thermometry performed during the treatments of 64 fibroids in 50 women (mean age, 46.6 years +/- 4.5 [standard deviation]) was used to create thermal dose maps. The areas that reached dose values of 240 and 18 equivalent minutes at 43 degrees C were compared with the nonperfused regions measured on contrast material-enhanced MR images by using the Bland-Altman method. Volume changes in treated fibroids after 6 months were compared with volume changes in nontreated fibroids and with MR-based thermal dose estimates. RESULTS: While the thermal dose estimates were shown to have a clear relationship with resulting nonperfused regions, the nonperfused areas were, on average, larger than the dose estimates (means of 1.9 +/- 0.7 and 1.2 +/- 0.4 times as large for areas that reached 240- and 18-minute threshold dose values, respectively). Good correlation was observed for smaller treatment volumes at the lower dose threshold (mean ratio, 1.0 +/- 0.3), but for larger treatment volumes, the nonperfused region extended to locations within the fibroid that clearly were not heated. Variations in peak temperature increase were as large as a factor of two, both between patients and within individual treatments. On average, the fibroid volume reduction at 6 months increased as the ablated volume estimated by using the thermal dose increased. CONCLUSION: Study results showed good correlation between thermal dose estimates and resulting nonperfused areas for smaller ablated volumes. For larger treatment volumes, nonperfused areas could extend within the fibroid to unheated areas.
机译:目的:回顾性评估子宫平滑肌瘤(即肌瘤)超声聚焦治疗过程中基于磁共振(MR)成像的测温法和热剂量法。材料与方法:所有患者均接受了聚焦超声治疗的书面知情同意书以及当前符合HIPAA要求的回顾性研究,均获得了机构审查委员会的批准。在50位女性(平均年龄46.6岁+/- 4.5 [标准差])中治疗64例肌瘤期间进行的体温计用于创建热剂量图。通过使用Bland-Altman方法,将在43摄氏度达到240和18当量分钟剂量值的区域与在增强造影剂的MR图像上测量的非灌注区域进行了比较。将6个月后治疗的肌瘤的体积变化与未治疗的肌瘤的体积变化以及基于MR的热剂量估算值进行比较。结果:虽然热剂量估计值与产生的非灌注区域有明确的关系,但平均而言,非灌注区域要比剂量估计大(均值的1.9 +/- 0.7和1.2 +/- 0.4倍分别达到240分钟和18分钟阈值剂量值的区域)。在较低的剂量阈值(平均比,1.0 +/- 0.3)下,较小的治疗体积观察到良好的相关性,但对于较大的治疗体积,未灌注区域扩展至明显未加热的肌瘤位置。在患者之间以及在个别治疗中,峰值温度升高的变化最大为两倍。平均而言,随着使用热剂量估计的消融体积增加,在6个月时的肌瘤体积减少增加。结论:研究结果表明,对于较小的消融量,热剂量估算值与产生的非灌注面积之间具有良好的相关性。对于更大的治疗量,非灌注区域可在肌瘤内延伸至未加热区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号